Table 2.
The effect of sodium selenite on serum, liver, and kidney CAT activity in alloxan-induced diabetic rats (Values represented as mean ± S.D).
| Experimental groups | Serum | Kidney | Liver | |
|---|---|---|---|---|
| CAT activity (U/mg protein) |
Control (non-diabetic untreated) | 83.49 ± 29.71* | 89.88 ± 19.01* | 84.94 ± 23.55* |
| Non-diabetic treated | 76.45 ± 21.43* | 53.84 ± 20.02 | 61.26 ± 11.77* | |
| Diabetic untreated | 46.00 ± 7.27 | 46.75 ± 10.39 | 26.13 ± 7.94 | |
| Diabetic treated | 71.63 ± 19.68* | 45.71 ± 23.75# | 58.84 ± 23.91* # | |
*
P < .05 compared with diabetic untreated group.
#
P < .05 compared with controls.